The US Food and Drug Administration (FDA) has granted clearance for Roche's Elecsys pTau181 test, a blood-based biomarker ...

Latent class models (LCMs) have emerged as a vital statistical tool in the evaluation of diagnostic tests, particularly in settings where no definitive gold standard is available. These models operate ...

Correspondence to Dr Meagan M Wasfy, Cardiovascular Performance Program, Massachusetts General Hospital, Boston, MA 02114, USA; mwasfy{at}partners.org Objectives Persistent or late-onset ...

UAE schools are embracing a smarter academic year with new diagnostic assessments to pinpoint student strengths and ...

In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid ...

Recommendations designed to reframe the evaluation of in vitro diagnostic tests have been published today by the Royal Statistical Society in its Series A journal. The report, which will be submitted ...

Recommendations designed to reframe the evaluation of in vitro diagnostic tests have been published today by the Royal Statistical Society in its Series A journal. The report, which will be submitted ...

The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the ...

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...

GRAND RAPIDS, MICHIGAN / ACCESS Newswire / October 1, 2025 / Quintessence Psychiatry, a telepsychiatry practice led by Nona Kocher, MPH, MD, has adopted Mentavi Health‘s asynchronous Diagnostic ...